VITAVOLT GLOBAL · EVIDENCE
Investment Evidence Center

Evidence before claims.

This page separates what exists today from what is being validated and what remains a future target. It is designed to give investors, partners and research collaborators a clear public evidence trail.

Public evidence today

Published portfolio evidence
Engineering

7.264 kWp technical portfolio

Vitavolt's public website identifies a published technical portfolio totaling 7.264 kWp. This is evidence of the engineering portfolio, not a claim about VITA customer traction.

View technical studies →
Live
Product

VITA Quick Feasibility

The website currently presents VITA Quick Feasibility as a working preliminary feasibility calculator. It is the live product entry point; broader investment-intelligence capabilities remain a development direction.

View VITA →
Research / development
AI

ANNE AI

ANNE is presented as AI research and development. The public positioning does not claim completed AGI or autonomous general intelligence.

View ANNE research →

Validation roadmap

These are targets and measurement plans, not current traction claims.

Stage 1

Real-project validation

Measure manual analysis time versus VITA analysis time, outputs, differences, missing data and investment decisions across real projects.

Stage 2

Commercial validation

Convert validated workflows into paid VITA engagements and measure repeatability, customer value and a sustainable revenue model.

Stage 3

Investor evidence

Publish appropriate aggregate KPIs, prepare a data room and document product, market, IP and financial evidence before a larger financing process.

What is deliberately not claimed

No invented traction.
We do not publish customer counts, revenue, pilot numbers, accuracy percentages, time savings or investment commitments unless they are supported by documented evidence. Future targets such as 10 real projects, 3–5 paying customers and a €1–2M financing target remain roadmap objectives until achieved.
No research-to-product shortcut.
Oxygen ClimateTech, SOLIS-LUMEN, EDCS and ANNE research are kept separate from commercial product claims and should be evaluated according to their own maturity and evidence.

Evidence network

Public sources are connected so that a reviewer can move from the investment thesis to the underlying technical and research material.